You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. TANGO THERAPEUTICS INC

Tango Therapeutics Inc

XNAS: TNGX

Weak Stock
Download real time

1.95 0.00 (0.00%)

New 52W Low in past week

402.0K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
22W
2O
1T
210.8

Market Cap

Below industry Median
-1.6

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
1.1

Price to Book

Below industry Median
0.5

Beta 1Year

Very Low volatility
Board Meeting
The board meeting for Tango Therapeutics Inc is scheduled for today, for the purpose of Tango Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Tango Therapeutics Inc

The latest disclosure was made by Douglas Barry in Tango Therapeutics Inc where a trade of 2,774 Common Stock done at an average price of $3.0 was reported to US exchanges on Feb. 4, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Douglas Barry General Counsel Sale of securities on an exchange or to another person at price $ 2.99 per share. 04 Feb 2025 2,774 68,570 - 3.0 8,289 Common Stock
Douglas Barry General Counsel Sale of securities on an exchange or to another person at price $ 3.16 per share. 04 Feb 2025 2,556 66,014 - 3.2 8,081 Common Stock
Adam Crystal See Remarks Sale of securities on an exchange or to another person at price $ 2.99 per share. 04 Feb 2025 7,432 165,061 - 3.0 22,207 Common Stock
Adam Crystal See Remarks Sale of securities on an exchange or to another person at price $ 3.16 per share. 04 Feb 2025 6,851 158,210 - 3.2 21,659 Common Stock
Barbara L. Weber Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.16 per share. 04 Feb 2025 9,013 1,622,251 - 3.2 28,494 Common Stock
Barbara L. Weber Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.99 per share. 04 Feb 2025 9,778 1,631,264 - 3.0 29,217 Common Stock
Daniella Beckman Chief Financial Officer Sale of securities on an exchange or to another person at price $ 2.99 per share. 04 Feb 2025 4,284 154,232 - 3.0 12,801 Common Stock
Daniella Beckman Chief Financial Officer Sale of securities on an exchange or to another person at price $ 3.16 per share. 04 Feb 2025 3,948 150,284 - 3.2 12,481 Common Stock
Adam Crystal See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 318,090 318,090 - - Stock Option (Right to Buy)
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 156,713 156,713 - - Stock Option (Right to Buy)
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 26,119 158,516 - 0 Common Stock
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 105,875 1,641,042 - 0 Common Stock
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 635,250 635,250 - - Stock Option (Right to Buy)
Adam Crystal See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 53,015 172,493 - 0 Common Stock
Douglas Barry General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 27,363 71,344 - 0 Common Stock
Douglas Barry General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 164,175 164,175 - - Stock Option (Right to Buy)
Mace Rothenberg Director Purchase of securities on an exchange or from another person at price $ 3.62 per share. 14 Nov 2024 10,000 21,250 - 3.6 36,200 Common Stock
Mace Rothenberg Director Purchase of securities on an exchange or from another person at price $ 3.78 per share. 14 Nov 2024 10,000 31,250 - 3.8 37,800 Common Stock
Aaron I. Davis See remarks. Other type of transaction at price $ 0.00 per share. 03 Sep 2024 65,000 65,000 - - Stock Option (Right to Buy)
Mace Rothenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,250 11,250 - 0 Common Stock
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,250 11,250 - 0 Common Stock
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 37,500 37,500 - - Stock Option (Right to Buy)
Lesley Ann Calhoun Director Sale of securities on an exchange or to another person at price $ 7.21 per share. 05 Jun 2024 5,000 6,250 - 7.2 36,039 Common Stock
Lesley Ann Calhoun Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,250 11,250 - 0 Common Stock
Lesley Ann Calhoun Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 37,500 37,500 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,250 11,250 - 0 Common Stock
Mace Rothenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 37,500 37,500 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 37,500 37,500 - - Stock Option (Right to Buy)
John B. Ketchum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 28,125 28,125 - - Stock Option (Right to Buy)
John B. Ketchum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,687 14,687 - 0 Common Stock
Barbara L. Weber Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 12.56 per share. 06 Feb 2024 4,681 1,539,624 - 12.6 58,806 Common Stock
Daniella Beckman Chief Financial Officer Sale of securities on an exchange or to another person at price $ 12.56 per share. 06 Feb 2024 1,908 134,214 - 12.6 23,969 Common Stock
Beckman Daniella Chief Financial Officer Sale of securities on an exchange or to another person at price $ 12.62 per share. 06 Feb 2024 1,817 132,397 - 12.6 22,930 Common Stock
Crystal Adam See Remarks Sale of securities on an exchange or to another person at price $ 12.62 per share. 06 Feb 2024 4,083 119,478 - 12.6 51,527 Common Stock
Barry Douglas General Counsel Sale of securities on an exchange or to another person at price $ 12.62 per share. 06 Feb 2024 1,354 43,981 - 12.6 17,087 Common Stock
L. Weber Barbara Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 12.62 per share. 06 Feb 2024 4,457 1,535,167 - 12.6 56,246 Common Stock
Crystal Adam See Remarks Sale of securities on an exchange or to another person at price $ 12.56 per share. 06 Feb 2024 4,288 123,561 - 12.6 53,868 Common Stock
Barry Douglas General Counsel Sale of securities on an exchange or to another person at price $ 12.56 per share. 06 Feb 2024 1,422 45,335 - 12.6 17,864 Common Stock
Barry Douglas General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 137,156 137,156 - - Stock Option (Right to Buy)
Barry Douglas General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 22,859 22,859 - 0 Common Stock
Adam Crystal See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 279,593 279,593 - - Stock Option (Right to Buy)
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 523,012 523,012 - - Stock Option (Right to Buy)
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 87,168 87,168 - 0 Common Stock
Crystal Adam See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 46,599 46,599 - 0 Common Stock
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 236,475 236,475 - - Stock Option (Right to Buy)
Beckman Daniella Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 39,413 39,413 - 0 Common Stock
John B. Ketchum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Aug 2023 60,000 60,000 - - Stock Option (Right to Buy)
John B. Ketchum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Aug 2023 10,000 10,000 - 0 Common Stock
Lesley Ann Calhoun Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Reid M. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Reid M. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Lesley Ann Calhoun Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Aaron I. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Aaron I. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Mace Rothenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 5,000 5,000 - 0 Common Stock
Mace Rothenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Alan Huang Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 190,181 190,181 - - Stock Option (Right to Buy)
Douglas Barry General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 143,391 143,391 - - Stock Option (Right to Buy)
Douglas Barry General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 23,898 23,898 - 0 Common Stock
Alan Huang Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 31,697 167,584 - 0 Common Stock
Adam Crystal See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 487,500 487,500 - - Stock Option (Right to Buy)
Adam Crystal See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 81,250 81,250 - 0 Common Stock
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 537,273 537,273 - - Stock Option (Right to Buy)
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 89,545 1,457,137 - 0 Common Stock
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 197,051 197,051 - - Stock Option (Right to Buy)
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 32,842 96,709 - 0 Common Stock
Aaron Weitzman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2022 350,000 350,000 - - Stock Option (Right to Buy)
Alexis A. Borisy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Reid M. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Lesley Ann Calhoun Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Mace Rothenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Aaron I. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Douglas Barry General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 69,500 69,500 - - Stock Option (Right to Buy)
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 150,000 150,000 - - Stock Option (Right to Buy)
Barbara L. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 625,000 625,000 - - Stock Option (Right to Buy)
Alan Huang Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 200,000 200,000 - - Stock Option (Right to Buy)
Daniella Beckman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2021 380,485 380,485 - - Stock Option (Right to Buy)
Alan Huang Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2021 169,859 169,859 - - Stock Option (Right to Buy)
Barbara Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2021 961,403 961,403 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters